Published in J Exp Med on November 01, 1969
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev (1980) 13.40
Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev (1989) 7.80
M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun (1972) 6.29
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Parameters affecting the adherence and tissue tropisms of Streptococcus pyogenes. Infect Immun (1974) 3.73
Proportional distribution and relative adherence of Streptococcus miteor (mitis) on various surfaces in the human oral cavity. Infect Immun (1972) 3.70
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
M proteins of group A streptococci. Bacteriol Rev (1974) 3.15
Simplified extraction procedure for serological grouping of beta-hemolytic streptococci. Appl Microbiol (1974) 3.12
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A (1987) 2.90
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol (1992) 2.66
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Study of cycle of cell wall assembly in Streptococcus faecalis by three-dimensional reconstructions of thin sections of cells. J Bacteriol (1976) 2.25
Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Role of M protein in adherence of group A streptococci. Infect Immun (1991) 2.05
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
Serogrouping of beta-hemolytic streptococci from throat swabs with nitrous acid extraction and the Phadebact streptococcus test. J Clin Microbiol (1982) 1.92
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Serogrouping single colonies of beta-hemolytic streptococci from primary throat culture plates with nitrous acid extraction and Phadebact streptococcal reagents. J Clin Microbiol (1980) 1.80
Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes. Infect Immun (1972) 1.80
Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Ultrastructure of Mutants of Streptococcus mutans with Reference to Agglutination, Adhesion, and Extracellular Polysaccharide. Infect Immun (1974) 1.70
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med (1988) 1.63
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Listeria monocytogenes surface proteins: from genome predictions to function. Microbiol Mol Biol Rev (2007) 1.59
A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. Infect Immun (1989) 1.58
Opsonin system of the group B streptococcus. Infect Immun (1974) 1.53
Serology of Streptococcus sanguis: localization of antigens with unlabeled antisera. Infect Immun (1973) 1.52
Three-dimensional reconstruction of whole cells of Streptococcus faecalis from thin sections of cells. J Bacteriol (1976) 1.47
Identification and preliminary characterization of a Streptococcus sanguis fibrillar glycoprotein. J Bacteriol (1987) 1.47
Membrane lipoteichoic acid of Streptococcus pyogenes and its stabilized L-form and the effect of two antibiotics upon its cellular content. J Bacteriol (1976) 1.42
Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci. Infect Immun (1987) 1.39
Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin. Proc Natl Acad Sci U S A (1979) 1.38
Negative staining and immunoelectron microscopy of adhesion-deficient mutants of Streptococcus salivarius reveal that the adhesive protein antigens are separate classes of cell surface fibril. J Bacteriol (1986) 1.38
Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule. J Exp Med (1986) 1.34
Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun (2001) 1.34
Study of cell wall growth in Bacillus megaterium by high-resolution autoradiography. J Bacteriol (1975) 1.33
Primary structure of streptococcal Pep M5 protein: Absence of extensive sequence repeats. Proc Natl Acad Sci U S A (1983) 1.33
Polar localization of virulence-related Esx-1 secretion in mycobacteria. PLoS Pathog (2009) 1.32
Bacteriophage control of antiphagocytic determinants in group A streptococci. J Exp Med (1980) 1.25
Streptococcal M protein size mutants occur at high frequency within a single strain. J Exp Med (1986) 1.25
Effect of Bactericidal Substance from Staphylococcus aureus on Group A Streptococci II. Structural Alterations. Infect Immun (1970) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Comparison of three methods for grouping streptococci. J Clin Microbiol (1976) 1.23
Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem. J Exp Med (1987) 1.23
Sortase A localizes to distinct foci on the Streptococcus pyogenes membrane. Proc Natl Acad Sci U S A (2008) 1.20
Electron microscopic studies on streptococci. II. Group A carbohydrate. J Exp Med (1973) 1.16
M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun (1998) 1.12
Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem J (1995) 1.08
Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes. Infect Immun (1977) 1.08
Purification and characterization of group A streptococcal T-1 antigen. Infect Immun (1977) 1.07
Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci. Infect Immun (1985) 1.06
Electron microscopy of group A streptococci after phagocytosis by human monocytes. Infect Immun (1971) 1.06
Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem. J Exp Med (1986) 1.03
Purification and characterization of surface fibrils from taxonomically typical Actinomyces viscosus WVU627. J Bacteriol (1981) 1.03
Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent. Infect Immun (1998) 1.03
Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Infect Immun (1991) 1.02
Immunoelectron microscopic identification and localization of Streptococcus sanguis with peroxidase-labeled antibody: localization of surface antigens in pure cultures. Infect Immun (1975) 1.01
Colony morphology of piliated Neisseria meningitidis. J Exp Med (1989) 0.98
Vimentin-cross-reactive epitope of type 12 streptococcal M protein. Infect Immun (1989) 0.98
Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans. Infect Immun (1986) 0.97
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother (1978) 0.97
Cell wall polysaccharide biosynthesis by membrane fragments from Streptococcus pyogenes and stabilized L-form. J Bacteriol (1971) 0.97
Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival. MBio (2013) 0.95
Streptococcal rheumatic carditis. Microbiol Rev (1983) 0.94
Genomic sequence of C1, the first streptococcal phage. J Bacteriol (2003) 0.93
Renal autoimmune epitope of group A streptococci specified by M protein tetrapeptide Ile-Arg-Leu-Arg. Proc Natl Acad Sci U S A (1988) 0.92
Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes. Infect Immun (1976) 0.91
Difference in the structural features of streptococcal M proteins from nephritogenic and rheumatogenic serotypes. J Exp Med (1987) 0.90
Unexpectedly high levels of some presumably protective secretory immunoglobulin A antibodies to dental plaque bacteria in salivas of both caries-resistant and caries-susceptible subjects. Infect Immun (1993) 0.90
Cellular aspects of the distinct M protein and SfbI anchoring pathways in Streptococcus pyogenes. Mol Microbiol (2012) 0.87
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia. Antimicrob Agents Chemother (2014) 0.86
Strain-specific restriction of the antiphagocytic property of group A streptococcal M proteins. Infect Immun (2000) 0.85
Extraction of group A streptococcal M protein with nitrous acid. J Clin Microbiol (1981) 0.85
Autoimmune sequence of streptococcal M protein shared with the intermediate filament protein, vimentin. J Exp Med (1989) 0.84
An antiphagocytic factor associated with group E streptococcus. Infect Immun (1973) 0.82
Integration of bacteriophage SP24 into the chromosome of group A streptococci. J Bacteriol (1985) 0.81
Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein. Infect Immun (1989) 0.80
Phagocytosis and killing of Streptococcus pyogenes by human alveolar macrophages. Infect Immun (1981) 0.80
Surface protein of a Streptococcus agalactiae isolate. Infect Immun (1979) 0.79
Surface interactome in Streptococcus pyogenes. Mol Cell Proteomics (2011) 0.78
Electron microscopic localization of receptors for aggregated beta 2-microglobulin on the surface of beta-hemolytic streptococci. Infect Immun (1983) 0.78
Heterogeneity of group A type-specific antibodies. Infect Immun (1980) 0.78
Functional and structural properties of a novel protein and virulence factor (Protein sHIP) in Streptococcus pyogenes. J Biol Chem (2014) 0.77
Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology. PLoS One (2015) 0.77
Multiparametric AFM reveals turgor-responsive net-like peptidoglycan architecture in live streptococci. Nat Commun (2015) 0.76
Structure and Interactions of a Dimeric Variant of sHIP, a Novel Virulence Determinant of Streptococcus pyogenes. Front Microbiol (2016) 0.75
A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPY. J Cell Biol (1965) 37.37
Electron microscope study of DNA-containing plasms. II. Vegetative and mature phage DNA as compared with normal bacterial nucleoids in different physiological states. J Biophys Biochem Cytol (1958) 36.70
Current knowledge of type-specific M antigens of group A streptococci. J Immunol (1962) 14.71
Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med (1957) 10.14
STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : I. EFFECTS OF PROTEOLYTIC ENZYMES ON STREPTOCOCCAL CELLS. J Exp Med (1943) 6.52
Cell wall replication in Streptococcus pyogenes. Science (1962) 6.05
THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med (1946) 5.62
Preparation of an electron-dense antibody conjugate. Nature (1959) 5.41
Symposium on the fine structure and replication of bacteria and their parts. 3. Bacterial cell-wall replication followed by immunofluorescence. Bacteriol Rev (1965) 4.75
Studies on the bacteriophages of hemolytic streptococci. II. Antigens released from the streptococcal cell wall by a phage-associated lysin. J Exp Med (1958) 4.70
Studies on the biosynthesis of the M-protein of group A hemolytic streptococci. J Bacteriol (1956) 2.47
STREPTOCOCCAL M ANTIGEN LOCATION AND SYNTHESIS, STUDIED BY IMMUNOFLUORESCENCE. J Exp Med (1963) 1.79
Measurement of streptococcal antigen synthesis with fluorescent antibody. Proc Soc Exp Biol Med (1962) 1.54
FLUORESCENT, ELECTRON MICROSCOPIC, AND IMMUNOELECTROPHORETIC STUDIES OF LABELED ANTIBODIES. Science (1963) 1.46
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns. J Exp Med (1971) 14.84
Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med (1969) 13.87
Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med (1969) 9.01
Type I Escherichia coli pili: characterization of binding to monkey kidney cells. J Exp Med (1977) 8.96
Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells. J Exp Med (1973) 8.95
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides. J Exp Med (1969) 8.30
Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci. Infect Immun (1978) 8.19
Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89
The serological classification of Neisseria gonorrhoeae. I. Isolation of the outer membrane complex responsible for serotypic specificity. J Exp Med (1976) 7.85
Hemagglutination by purified type I Escherichia coli pili. J Exp Med (1977) 7.61
Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures. Infect Immun (1978) 6.49
Nucleotide sequence of the maize transposable element Mul. Nucleic Acids Res (1984) 6.44
Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med (1969) 6.17
Isolation and characterization of the outer membrane of Neisseria gonorrhoeae. J Bacteriol (1974) 5.36
Studies on gonococcus infection. XIV. Cell wall protein differences among color/opacity colony variants of Neisseria gonorrhoeae. Infect Immun (1978) 5.08
An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. J Exp Med (1974) 4.90
Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection. J Clin Invest (1973) 4.90
Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med (1969) 3.96
The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol (1982) 3.92
DNA insertion in the first intron of maize Adh1 affects message levels: cloning of progenitor and mutant Adh1 alleles. Proc Natl Acad Sci U S A (1984) 3.89
Studies on gonococcus infection. XI. Comparison of in vivo and vitro association of Neisseria gonorrhoeae with human neutrophils. J Infect Dis (1978) 3.85
"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet (1997) 3.68
Studies on Gonococcus infection. X. Pili and leukocyte association factor as mediators of interactions between gonococci and eukaryotic cells in vitro. Infect Immun (1975) 3.63
Differential attachment by piliated and nonpiliated Neisseria gonorrhoeae to human sperm. Infect Immun (1974) 3.51
Gonococcal pili. Primary structure and receptor binding domain. J Exp Med (1984) 3.32
Surface-exposed protein antigens of the gonococcal outer membrane. Infect Immun (1981) 3.28
Angiotensin-converting enzyme: vascular endothelial localization. Science (1976) 3.22
Studies on gonococcus infection. 3. Correlation of gonococcal colony morphology with infectivity for the chick embryo. J Exp Med (1973) 3.22
Studies on gonococcus infection. XVIII. 125I-labeled peptide mapping of the major protein of the gonococcal cell wall outer membrane. Infect Immun (1979) 3.21
Studies on gonococcus infection. II. Freeze-fracture, freeze-etch studies on gonocci. J Exp Med (1972) 3.14
Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest (1972) 3.13
Colony opacity and protein II compositions of gonococci. Infect Immun (1982) 3.12
Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae. Cell (1986) 2.98
Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg (2001) 2.96
Piliation control mechanisms in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1986) 2.96
Lipid on capsular polysaccharides of gram-negative bacteria. J Biol Chem (1981) 2.91
Effects of proteolytic enzymes on the outer membrane proteins of Neisseria gonorrhoeae. Infect Immun (1981) 2.82
Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J Bacteriol (1976) 2.79
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Studies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharide. J Biol Chem (1971) 2.74
Structural and immunological studies on the pneumococcal C polysaccharide. J Biol Chem (1967) 2.73
Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae. Infect Immun (1982) 2.70
Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol (1970) 2.62
Studies on gonococcus infection. XV. Identification of surface proteins of Neisseria gonorrhoeae correlated with leukocyte association. Infect Immun (1978) 2.62
Gonococcal pilin variants in experimental gonorrhea. J Exp Med (1987) 2.62
Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms. Ann N Y Acad Sci (1966) 2.61
Tubular lysosome morphology and distribution within macrophages depend on the integrity of cytoplasmic microtubules. Proc Natl Acad Sci U S A (1987) 2.61
A simplification of the radioactive antigen-binding test by a double label technique. J Immunol (1971) 2.59
Studies on gonococcus infection. V. Observations on in vitro interactions of gonococci and human neutrophils. Infect Immun (1974) 2.57
Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun (1982) 2.48
Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Infect Immun (1972) 2.47
Electron microscopic studies on opaque colony variants of group A streptococci. J Bacteriol (1969) 2.46
Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun (1991) 2.46
Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry (1997) 2.42
Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis. J Clin Invest (1970) 2.41
Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics (1987) 2.39
Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharide. J Biol Chem (1971) 2.39
Pilus- gonococcal variants. Evidence for multiple forms of piliation control. J Exp Med (1985) 2.33
Gonococcal color and opacity variants: virulence for chicken embryos. Infect Immun (1978) 2.33
The serum bactericidal system: ultrastructural changes in Neisseria meningitidis exposed to normal rat serum. J Exp Med (1969) 2.32
A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ (1973) 2.29
The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Mol Microbiol (1991) 2.24
Electron microscopy of herpes simplex virus. IV. Studies with ferritin-conjugated antibodies. J Virol (1968) 2.22
A pilus peptide vaccine for the prevention of gonorrhea. Prog Allergy (1983) 2.19
125I-labeled peptide mapping of some heat-modifiable proteins of the gonococcal outer membrane. Infect Immun (1980) 2.18
Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae. J Exp Med (1984) 2.16
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest (1975) 2.16
Trichosporon beigelii infection: a review. Rev Infect Dis (1987) 2.15
Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores. J Am Acad Child Adolesc Psychiatry (1994) 2.14
Aspects on structure and function of pili on uropathogenic Escherichia coli. Prog Allergy (1983) 2.11
Morphogenesis of type 2 parainfluenza virus examined by light and electron microscopy. J Virol (1967) 2.08
Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry (2005) 2.06
Intra-strain heterogeneity of gonococcal pili is related to opacity colony variance. J Exp Med (1980) 2.04
Gonococcal pilus subunit size heterogeneity correlates with transitions in colony piliation phenotype, not with changes in colony opacity. J Exp Med (1983) 2.04
Localization of 11 S external secretory IgA by immunofluorescence in tissues lining the oral and respiratory passages in man. J Immunol (1968) 2.04
Interactions of gonococci with HeLa cells: attachment, detachment, replication, penetration, and the role of protein II. Infect Immun (1986) 2.01
The immunological responses observed in field studies in Africa with group A meningococcal vaccines. Prog Immunobiol Stand (1971) 1.96
Muramic acid phosphate as a component of the mucopeptide of Gram-positive bacteria. J Biol Chem (1967) 1.94
Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics (2001) 1.92
Immunological characteristics of gonococcal outer membrane protein II assessed by immunoprecipitation, immunoblotting, and coagglutination. J Exp Med (1983) 1.92
Studies on gonococcus infection. VIII. 125Iodine labeling of gonococci and studies on their in vitro interactions with eukaryotic cells. Infect Immun (1975) 1.91
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis (1977) 1.84
Recent victimization in women and men with severe mental illness: prevalence and correlates. J Trauma Stress (2001) 1.84
C-reactive protein: a molecule composed of subunits. Proc Natl Acad Sci U S A (1965) 1.84
The endocytic activity of dendritic cells. J Exp Med (1995) 1.82
The DNA sequence of the structural gene of gonococcal protein III and the flanking region containing a repetitive sequence. Homology of protein III with enterobacterial OmpA proteins. J Exp Med (1987) 1.81
Immunogenicity of the group A and group C meningococcal polysaccharides in children. J Infect Dis (1972) 1.81
Studies of Porins: Spontaneously Transferred from Whole Cells and Reconstituted from Purified Proteins of Neisseria gonorrhoeae and Neisseria meningitidis. Biophys J (1984) 1.79
Immune complex orchitis in vasectomized rabbits. J Exp Med (1976) 1.79
Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate. J Exp Med (1995) 1.77